| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |